Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 4
2(33.3%)
6Total
N/A(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07332910Phase 4Not Yet Recruiting

Study the Anti-inflammatory Effect of Tranexamic Acid When Used in Anterior Cruciate Ligament Reconstruction.

Role: collaborator

NCT03653325Not ApplicableCompleted

ORI to Reduce Hyperoxia After Out Hospital Cardiac Arrest

Role: collaborator

NCT03857893Not ApplicableTerminated

New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy

Role: collaborator

NCT01871753Phase 4Completed

The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria

Role: collaborator

NCT02113761Completed

Non Invasive Mapping Before Ablation for Atrial Fibrillation.

Role: collaborator

NCT01305421Not ApplicableUnknown

Grip Test in Ventilated ICU Patients

Role: lead

NCT01081392Not ApplicableUnknown

Inflammatory Markers in Sputum After LPS Inhalation

Role: lead

All 7 trials loaded